

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.72161412 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.59606901 |
| 3 | response to peptidoglycan (GO:0032494) | 5.85167148 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.62033557 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.62033557 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.62033557 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.62033557 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.62033557 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.62033557 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.39550828 |
| 11 | negative regulation of cell killing (GO:0031342) | 5.12448714 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.12448714 |
| 13 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.06799671 |
| 14 | respiratory burst (GO:0045730) | 4.99978951 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.84094340 |
| 16 | cellular extravasation (GO:0045123) | 4.71417352 |
| 17 | granulocyte activation (GO:0036230) | 4.64470363 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.41593228 |
| 19 | positive regulation of mast cell activation (GO:0033005) | 4.39273721 |
| 20 | neutrophil activation (GO:0042119) | 4.31806131 |
| 21 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.28022002 |
| 22 | positive regulation of mast cell degranulation (GO:0043306) | 4.28022002 |
| 23 | superoxide anion generation (GO:0042554) | 4.16658359 |
| 24 | detection of bacterium (GO:0016045) | 4.16295930 |
| 25 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.11566415 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 4.11020379 |
| 27 | response to host immune response (GO:0052572) | 4.08972565 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.08972565 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 4.05518917 |
| 30 | myeloid cell activation involved in immune response (GO:0002275) | 4.04177434 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.01131251 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.01056640 |
| 33 | regulation of mast cell activation (GO:0033003) | 3.94899784 |
| 34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.93929634 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.92176756 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.90090491 |
| 37 | leukocyte aggregation (GO:0070486) | 3.87651917 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.83084653 |
| 39 | eosinophil chemotaxis (GO:0048245) | 3.81016716 |
| 40 | detection of biotic stimulus (GO:0009595) | 3.80588138 |
| 41 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.79382860 |
| 42 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.79173263 |
| 43 | microglial cell activation (GO:0001774) | 3.71538562 |
| 44 | macrophage activation (GO:0042116) | 3.70158259 |
| 45 | regulation of interferon-alpha production (GO:0032647) | 3.68809312 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 3.66858189 |
| 47 | reactive oxygen species biosynthetic process (GO:1903409) | 3.66337360 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64633312 |
| 49 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.64185299 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.62439299 |
| 51 | response to host (GO:0075136) | 3.62439299 |
| 52 | response to host defenses (GO:0052200) | 3.62439299 |
| 53 | neutrophil chemotaxis (GO:0030593) | 3.62338875 |
| 54 | eosinophil migration (GO:0072677) | 3.60767765 |
| 55 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.57167504 |
| 56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.57084888 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.56940955 |
| 58 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.54268212 |
| 59 | neutrophil migration (GO:1990266) | 3.52509920 |
| 60 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.49982114 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 3.48225675 |
| 62 | regulation of mononuclear cell migration (GO:0071675) | 3.44572236 |
| 63 | negative regulation of interleukin-17 production (GO:0032700) | 3.43481732 |
| 64 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.43254829 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.43198394 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37819465 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.37126496 |
| 68 | negative regulation of mast cell activation (GO:0033004) | 3.33035103 |
| 69 | neutrophil mediated immunity (GO:0002446) | 3.32851810 |
| 70 | granulocyte chemotaxis (GO:0071621) | 3.32654042 |
| 71 | positive regulation of macrophage cytokine production (GO:0060907) | 3.32178111 |
| 72 | positive regulation of leukocyte degranulation (GO:0043302) | 3.31583990 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 3.30315363 |
| 74 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.28784969 |
| 75 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.28719887 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28294411 |
| 77 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.25851728 |
| 78 | * positive regulation of monocyte chemotaxis (GO:0090026) | 3.23847191 |
| 79 | phagosome maturation (GO:0090382) | 3.23196586 |
| 80 | granulocyte migration (GO:0097530) | 3.22323883 |
| 81 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.21205034 |
| 82 | positive regulation of lymphocyte migration (GO:2000403) | 3.20521324 |
| 83 | response to type I interferon (GO:0034340) | 3.19741435 |
| 84 | regulation of tolerance induction (GO:0002643) | 3.19064960 |
| 85 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.18988553 |
| 86 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.17980228 |
| 87 | lymphocyte chemotaxis (GO:0048247) | 3.16742082 |
| 88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.15832322 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.13964662 |
| 90 | positive regulation of tumor necrosis factor production (GO:0032760) | 3.13228601 |
| 91 | amino sugar catabolic process (GO:0046348) | 3.12409329 |
| 92 | leukocyte mediated cytotoxicity (GO:0001909) | 3.12215685 |
| 93 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.11481115 |
| 94 | germinal center formation (GO:0002467) | 3.10869447 |
| 95 | detection of other organism (GO:0098543) | 3.10135284 |
| 96 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.10098759 |
| 97 | myeloid leukocyte activation (GO:0002274) | 3.06793586 |
| 98 | glycosphingolipid catabolic process (GO:0046479) | 3.06054655 |
| 99 | defense response to protozoan (GO:0042832) | 3.05079532 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04105882 |
| 101 | lipoxygenase pathway (GO:0019372) | 3.03012194 |
| 102 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.02570141 |
| 103 | monocyte chemotaxis (GO:0002548) | 3.01827419 |
| 104 | negative regulation of interleukin-12 production (GO:0032695) | 3.01656991 |
| 105 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.01537759 |
| 106 | myeloid dendritic cell differentiation (GO:0043011) | 3.00077976 |
| 107 | T-helper 1 type immune response (GO:0042088) | 2.99518689 |
| 108 | positive regulation of macrophage differentiation (GO:0045651) | 2.98705822 |
| 109 | regulation of antigen processing and presentation (GO:0002577) | 2.98531379 |
| 110 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.98322070 |
| 111 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94937028 |
| 112 | B cell mediated immunity (GO:0019724) | 2.94865248 |
| 113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94829709 |
| 114 | I-kappaB phosphorylation (GO:0007252) | 2.94576167 |
| 115 | detection of external biotic stimulus (GO:0098581) | 2.93042386 |
| 116 | positive regulation of type 2 immune response (GO:0002830) | 2.92171020 |
| 117 | response to fungus (GO:0009620) | 2.89755797 |
| 118 | T cell migration (GO:0072678) | 2.89281319 |
| 119 | myeloid leukocyte mediated immunity (GO:0002444) | 2.88482136 |
| 120 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.87480565 |
| 121 | positive regulation of interferon-beta production (GO:0032728) | 2.87474662 |
| 122 | oligosaccharide catabolic process (GO:0009313) | 2.86990853 |
| 123 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86211440 |
| 124 | regulation of lymphocyte migration (GO:2000401) | 2.85907866 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 2.85335739 |
| 126 | regulation of regulated secretory pathway (GO:1903305) | 2.84332215 |
| 127 | leukocyte degranulation (GO:0043299) | 2.83086397 |
| 128 | positive regulation of B cell differentiation (GO:0045579) | 2.80729789 |
| 129 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80722903 |
| 130 | cellular response to type I interferon (GO:0071357) | 2.80450916 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.80450916 |
| 132 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.79894067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.91726403 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.02264737 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71446619 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.58435166 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.27094473 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.85629075 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.83274572 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43568677 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.37163929 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23420040 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.98410350 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98338414 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88242447 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73685408 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.68101789 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.66711796 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50709000 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43190415 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.29821488 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24174315 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.17084928 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.03371364 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87772574 |
| 24 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.82321855 |
| 25 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.75797183 |
| 26 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74302542 |
| 27 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.72598645 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72221446 |
| 29 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.71466846 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68517526 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67764978 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67742949 |
| 33 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66441424 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63900401 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61841556 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57830479 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.56771918 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55157046 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.51107001 |
| 40 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50090463 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48210179 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47096841 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46398096 |
| 44 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45200928 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43235381 |
| 46 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34943818 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.32468937 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31945286 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28423157 |
| 50 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27509383 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.24975215 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22339248 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22163394 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21680120 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.19621843 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19485622 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19295173 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16538895 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15843440 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15245068 |
| 61 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.15082293 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13479822 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12600624 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12386201 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12272327 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10849101 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08542056 |
| 68 | MYB_26560356_Chip-Seq_TH1_Human | 1.07329326 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06174227 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05328352 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03701876 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03429176 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03001032 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02987651 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01872902 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01208830 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99549463 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99092597 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97294725 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93917705 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92108559 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92009611 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90650726 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90650726 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88341029 |
| 86 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88247274 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87746828 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85349791 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82491586 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80953846 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79254369 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78323760 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76545484 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76033233 |
| 95 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75948516 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75717645 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75376431 |
| 98 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74689922 |
| 99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.74682052 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.74432553 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74305752 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73721865 |
| 103 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73580592 |
| 104 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.71734214 |
| 105 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71562897 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.71268549 |
| 107 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.70020005 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.67782464 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 0.66799380 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65988227 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 0.65771796 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.65620315 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64159915 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63839949 |
| 115 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.62512866 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.62317965 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.61807245 |
| 118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.61807245 |
| 119 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.61797321 |
| 120 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.61518622 |
| 121 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61203604 |
| 122 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.58640237 |
| 123 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.56736086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.79603251 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.65400715 |
| 3 | MP0003303_peritoneal_inflammation | 3.81521386 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 3.75855379 |
| 5 | MP0009785_altered_susceptibility_to | 3.67972160 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.55039014 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.38959326 |
| 8 | MP0006082_CNS_inflammation | 3.33095061 |
| 9 | MP0003724_increased_susceptibility_to | 3.21849966 |
| 10 | * MP0005025_abnormal_response_to | 3.07568622 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.71710688 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.66888540 |
| 13 | MP0001533_abnormal_skeleton_physiology | 2.55276384 |
| 14 | MP0001790_abnormal_immune_system | 2.47480752 |
| 15 | MP0005387_immune_system_phenotype | 2.47480752 |
| 16 | MP0005671_abnormal_response_to | 2.40957811 |
| 17 | * MP0002723_abnormal_immune_serum | 2.40807977 |
| 18 | MP0001800_abnormal_humoral_immune | 2.36940623 |
| 19 | MP0001853_heart_inflammation | 2.34831679 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.27157721 |
| 21 | MP0001819_abnormal_immune_cell | 2.23809915 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.21563843 |
| 23 | MP0009764_decreased_sensitivity_to | 2.14220254 |
| 24 | MP0004510_myositis | 2.13416011 |
| 25 | MP0003075_altered_response_to | 2.12639956 |
| 26 | MP0000685_abnormal_immune_system | 2.08744942 |
| 27 | * MP0000343_altered_response_to | 2.05893130 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.97750949 |
| 29 | MP0003448_altered_tumor_morphology | 1.95491506 |
| 30 | * MP0001845_abnormal_inflammatory_respons | 1.92417620 |
| 31 | * MP0002405_respiratory_system_inflammati | 1.91960106 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.82216612 |
| 33 | MP0003690_abnormal_glial_cell | 1.81024560 |
| 34 | MP0005166_decreased_susceptibility_to | 1.77692936 |
| 35 | MP0005451_abnormal_body_composition | 1.77268539 |
| 36 | MP0000604_amyloidosis | 1.76941669 |
| 37 | MP0009278_abnormal_bone_marrow | 1.74774417 |
| 38 | MP0009840_abnormal_foam_cell | 1.69588243 |
| 39 | MP0004947_skin_inflammation | 1.67015164 |
| 40 | MP0008469_abnormal_protein_level | 1.63973792 |
| 41 | MP0003828_pulmonary_edema | 1.63844480 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.62609303 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.50547279 |
| 44 | MP0005164_abnormal_response_to | 1.47945607 |
| 45 | MP0005310_abnormal_salivary_gland | 1.46133785 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.46094433 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.43724209 |
| 48 | * MP0000716_abnormal_immune_system | 1.43474169 |
| 49 | MP0000858_altered_metastatic_potential | 1.39237227 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.32995006 |
| 51 | MP0002398_abnormal_bone_marrow | 1.27315592 |
| 52 | MP0004883_abnormal_blood_vessel | 1.26573529 |
| 53 | MP0005390_skeleton_phenotype | 1.22146885 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.19649771 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.19309176 |
| 56 | MP0002933_joint_inflammation | 1.17761685 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.17056692 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.16461345 |
| 59 | MP0001851_eye_inflammation | 1.15350396 |
| 60 | MP0002006_tumorigenesis | 1.12963189 |
| 61 | * MP0002429_abnormal_blood_cell | 1.12847828 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.12274597 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.10121934 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.10076600 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.09022530 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.08657115 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.08657115 |
| 68 | MP0002132_abnormal_respiratory_system | 1.07372379 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.04093200 |
| 70 | MP0003329_amyloid_beta_deposits | 1.02341660 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 0.99128703 |
| 72 | MP0002722_abnormal_immune_system | 0.97287847 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 0.96701464 |
| 74 | MP0009763_increased_sensitivity_to | 0.95287216 |
| 75 | MP0003186_abnormal_redox_activity | 0.94402374 |
| 76 | MP0003279_aneurysm | 0.92212272 |
| 77 | MP0000920_abnormal_myelination | 0.90746165 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.88095796 |
| 79 | MP0000249_abnormal_blood_vessel | 0.87777941 |
| 80 | MP0000703_abnormal_thymus_morphology | 0.80181837 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.77860917 |
| 82 | MP0003795_abnormal_bone_structure | 0.75399482 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.74728391 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.73235624 |
| 85 | MP0001663_abnormal_digestive_system | 0.72925729 |
| 86 | MP0008260_abnormal_autophagy | 0.71796844 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.69980293 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.68396621 |
| 89 | MP0003091_abnormal_cell_migration | 0.67375359 |
| 90 | MP0004381_abnormal_hair_follicle | 0.66829971 |
| 91 | MP0008874_decreased_physiological_sensi | 0.66662683 |
| 92 | MP0002254_reproductive_system_inflammat | 0.65544642 |
| 93 | MP0005023_abnormal_wound_healing | 0.65410443 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.62963232 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.62796517 |
| 96 | MP0000371_diluted_coat_color | 0.62329760 |
| 97 | MP0010307_abnormal_tumor_latency | 0.61779290 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.60272092 |
| 99 | MP0000490_abnormal_crypts_of | 0.59343967 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.59136467 |
| 101 | MP0004808_abnormal_hematopoietic_stem | 0.58617558 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58502499 |
| 103 | MP0003045_fibrosis | 0.57253037 |
| 104 | MP0008438_abnormal_cutaneous_collagen | 0.57180117 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.56963193 |
| 106 | MP0003866_abnormal_defecation | 0.56545182 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.55090036 |
| 108 | MP0002396_abnormal_hematopoietic_system | 0.54100640 |
| 109 | MP0008004_abnormal_stomach_pH | 0.52952241 |
| 110 | MP0000609_abnormal_liver_physiology | 0.52345929 |
| 111 | MP0005165_increased_susceptibility_to | 0.51530201 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.49776715 |
| 113 | MP0006054_spinal_hemorrhage | 0.49018936 |
| 114 | MP0003705_abnormal_hypodermis_morpholog | 0.47659078 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.46294908 |
| 116 | MP0009115_abnormal_fat_cell | 0.45489393 |
| 117 | MP0008873_increased_physiological_sensi | 0.45392411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.61937338 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.10378930 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.64142011 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.48112379 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.64930726 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.26308675 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.14429166 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.79323428 |
| 9 | Recurrent skin infections (HP:0001581) | 4.75909045 |
| 10 | Gingivitis (HP:0000230) | 4.73424325 |
| 11 | Obstructive lung disease (HP:0006536) | 4.65769239 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 4.65769239 |
| 13 | Stomatitis (HP:0010280) | 4.47782029 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 4.07975803 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.04665082 |
| 16 | Myositis (HP:0100614) | 3.93636284 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.92848675 |
| 18 | Orchitis (HP:0100796) | 3.90015917 |
| 19 | Prostate neoplasm (HP:0100787) | 3.82654367 |
| 20 | Axonal loss (HP:0003447) | 3.81837435 |
| 21 | Disinhibition (HP:0000734) | 3.68364471 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.66944670 |
| 23 | Optic neuritis (HP:0100653) | 3.66944670 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 3.60536729 |
| 25 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.58771399 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44370248 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40619364 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40619364 |
| 29 | Glomerulonephritis (HP:0000099) | 3.31058756 |
| 30 | Cellulitis (HP:0100658) | 3.29914792 |
| 31 | Urticaria (HP:0001025) | 3.26376468 |
| 32 | Pustule (HP:0200039) | 3.24277837 |
| 33 | Thick nail (HP:0001805) | 3.14343018 |
| 34 | Agnosia (HP:0010524) | 3.11872235 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 3.10064875 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.06293601 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05498593 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05498593 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05498593 |
| 40 | Periodontitis (HP:0000704) | 3.05277628 |
| 41 | Joint hemorrhage (HP:0005261) | 3.03931689 |
| 42 | Dysostosis multiplex (HP:0000943) | 3.01774101 |
| 43 | Amyloidosis (HP:0011034) | 2.96643326 |
| 44 | Meningitis (HP:0001287) | 2.87644340 |
| 45 | Encephalitis (HP:0002383) | 2.85472426 |
| 46 | Basal ganglia calcification (HP:0002135) | 2.82918145 |
| 47 | T lymphocytopenia (HP:0005403) | 2.82248728 |
| 48 | Recurrent viral infections (HP:0004429) | 2.75620954 |
| 49 | Vasculitis (HP:0002633) | 2.75005099 |
| 50 | Mutism (HP:0002300) | 2.74026653 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.71788286 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61767884 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.61173462 |
| 54 | Osteomyelitis (HP:0002754) | 2.59169346 |
| 55 | Myocardial infarction (HP:0001658) | 2.55894302 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.55539085 |
| 57 | Petechiae (HP:0000967) | 2.52162330 |
| 58 | Recurrent pneumonia (HP:0006532) | 2.51804563 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48169792 |
| 60 | Chest pain (HP:0100749) | 2.45139477 |
| 61 | Hemoptysis (HP:0002105) | 2.41939723 |
| 62 | Abnormality of complement system (HP:0005339) | 2.41675966 |
| 63 | Hematochezia (HP:0002573) | 2.39900954 |
| 64 | Increased serum ferritin (HP:0003281) | 2.36722980 |
| 65 | Arterial thrombosis (HP:0004420) | 2.32763723 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.32223456 |
| 67 | Pulmonary embolism (HP:0002204) | 2.31721188 |
| 68 | Increased IgE level (HP:0003212) | 2.30215323 |
| 69 | Abnormality of the prostate (HP:0008775) | 2.29704636 |
| 70 | Nephritis (HP:0000123) | 2.29117253 |
| 71 | Episodic fever (HP:0001954) | 2.28641790 |
| 72 | Leukocytosis (HP:0001974) | 2.27904465 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.27719557 |
| 74 | Upper motor neuron abnormality (HP:0002127) | 2.27481523 |
| 75 | Purpura (HP:0000979) | 2.23460926 |
| 76 | Neuronal loss in central nervous system (HP:0002529) | 2.22662540 |
| 77 | Gingival bleeding (HP:0000225) | 2.22652273 |
| 78 | Polyneuropathy (HP:0001271) | 2.20750343 |
| 79 | Cheilitis (HP:0100825) | 2.20162922 |
| 80 | Gangrene (HP:0100758) | 2.19185913 |
| 81 | Osteolytic defects of the hand bones (HP:0009699) | 2.18958397 |
| 82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18958397 |
| 83 | Poor head control (HP:0002421) | 2.17287625 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.16426380 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16426380 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16287989 |
| 87 | Pathologic fracture (HP:0002756) | 2.11184843 |
| 88 | Keratoconjunctivitis (HP:0001096) | 2.09953185 |
| 89 | Premature loss of primary teeth (HP:0006323) | 2.09788724 |
| 90 | Sepsis (HP:0100806) | 2.08953803 |
| 91 | Increased IgM level (HP:0003496) | 2.07138061 |
| 92 | Inflammation of the large intestine (HP:0002037) | 2.03355961 |
| 93 | Skin ulcer (HP:0200042) | 2.02200116 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 2.01535800 |
| 95 | Complement deficiency (HP:0004431) | 2.00935457 |
| 96 | Progressive neurologic deterioration (HP:0002344) | 2.00096832 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.98628729 |
| 98 | Colitis (HP:0002583) | 1.98144717 |
| 99 | Vertigo (HP:0002321) | 1.97600199 |
| 100 | Abnormality of T cells (HP:0002843) | 1.97483121 |
| 101 | Hypergammaglobulinemia (HP:0010702) | 1.95815951 |
| 102 | Abnormality of the endocardium (HP:0004306) | 1.95712748 |
| 103 | Epistaxis (HP:0000421) | 1.95462353 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95293528 |
| 105 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95293528 |
| 106 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95293528 |
| 107 | Progressive visual loss (HP:0000529) | 1.94930494 |
| 108 | Apathy (HP:0000741) | 1.92198309 |
| 109 | Glomerulopathy (HP:0100820) | 1.92195090 |
| 110 | Loss of speech (HP:0002371) | 1.91723828 |
| 111 | Increased CSF protein (HP:0002922) | 1.90577893 |
| 112 | Abnormality of the pericardium (HP:0001697) | 1.89602558 |
| 113 | Menorrhagia (HP:0000132) | 1.88125469 |
| 114 | Anorexia (HP:0002039) | 1.85357657 |
| 115 | Chronic otitis media (HP:0000389) | 1.85119142 |
| 116 | Amaurosis fugax (HP:0100576) | 1.85091154 |
| 117 | Peritonitis (HP:0002586) | 1.84643342 |
| 118 | Bone pain (HP:0002653) | 1.82839842 |
| 119 | Restrictive lung disease (HP:0002091) | 1.82062786 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 1.80994180 |
| 121 | Esophageal neoplasm (HP:0100751) | 1.77944378 |
| 122 | Neoplasm of head and neck (HP:0012288) | 1.77944378 |
| 123 | Prolonged bleeding time (HP:0003010) | 1.77508563 |
| 124 | J-shaped sella turcica (HP:0002680) | 1.76881380 |
| 125 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75477010 |
| 126 | Inappropriate behavior (HP:0000719) | 1.73210593 |
| 127 | Diminished motivation (HP:0000745) | 1.73207090 |
| 128 | Abnormality of T cell number (HP:0011839) | 1.71111639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.19584978 |
| 2 | RIPK4 | 3.92069100 |
| 3 | MAP3K14 | 3.35952488 |
| 4 | IRAK4 | 3.14096455 |
| 5 | PBK | 3.00515374 |
| 6 | IRAK3 | 2.92923351 |
| 7 | MAP4K1 | 2.87621562 |
| 8 | TYK2 | 2.72543548 |
| 9 | TBK1 | 2.67299650 |
| 10 | MST4 | 2.55676237 |
| 11 | TXK | 2.52883323 |
| 12 | PRPF4B | 2.38562782 |
| 13 | ERN1 | 1.92670486 |
| 14 | KIT | 1.89214560 |
| 15 | CSK | 1.82950380 |
| 16 | PIM2 | 1.81572109 |
| 17 | IKBKB | 1.79358767 |
| 18 | ZAP70 | 1.76171977 |
| 19 | FGR | 1.73087512 |
| 20 | EPHB1 | 1.73063649 |
| 21 | GRK7 | 1.71167620 |
| 22 | IKBKE | 1.64759148 |
| 23 | HCK | 1.63668166 |
| 24 | JAK1 | 1.62965029 |
| 25 | BTK | 1.62312245 |
| 26 | TAOK1 | 1.60671850 |
| 27 | SYK | 1.55688158 |
| 28 | JAK3 | 1.54263392 |
| 29 | FES | 1.49606528 |
| 30 | BMX | 1.47704466 |
| 31 | MST1R | 1.47447489 |
| 32 | NEK9 | 1.47332018 |
| 33 | TEC | 1.47067997 |
| 34 | TGFBR2 | 1.38948257 |
| 35 | LYN | 1.37966545 |
| 36 | CLK1 | 1.37763510 |
| 37 | STK10 | 1.35833172 |
| 38 | TAOK3 | 1.29650584 |
| 39 | TRPM7 | 1.28891768 |
| 40 | ABL2 | 1.22328240 |
| 41 | CSF1R | 1.19360777 |
| 42 | PIM1 | 1.15026444 |
| 43 | ACVR1B | 1.08797132 |
| 44 | MATK | 1.08549350 |
| 45 | KSR2 | 1.07615916 |
| 46 | LCK | 1.05721547 |
| 47 | MAP3K13 | 1.05500537 |
| 48 | JAK2 | 1.05398733 |
| 49 | ITK | 1.04227161 |
| 50 | IRAK2 | 1.01623258 |
| 51 | CDC42BPA | 1.01319771 |
| 52 | TESK2 | 0.93013261 |
| 53 | SIK3 | 0.92988866 |
| 54 | ADRBK2 | 0.92364965 |
| 55 | ARAF | 0.90834391 |
| 56 | ERBB3 | 0.90757199 |
| 57 | CAMKK2 | 0.90232894 |
| 58 | PRKCD | 0.88089661 |
| 59 | YES1 | 0.85878444 |
| 60 | MAP2K3 | 0.83929723 |
| 61 | BMPR2 | 0.83039068 |
| 62 | CHUK | 0.82888247 |
| 63 | LRRK2 | 0.81772440 |
| 64 | GRK6 | 0.81759495 |
| 65 | MARK3 | 0.80774575 |
| 66 | NME2 | 0.78611333 |
| 67 | DDR2 | 0.76284641 |
| 68 | DMPK | 0.75350507 |
| 69 | ABL1 | 0.74384447 |
| 70 | RPS6KA4 | 0.71743191 |
| 71 | MAP3K3 | 0.69328217 |
| 72 | MARK2 | 0.67930248 |
| 73 | MAPK12 | 0.67147418 |
| 74 | EIF2AK2 | 0.66673123 |
| 75 | EGFR | 0.65350190 |
| 76 | STK4 | 0.64096588 |
| 77 | MAPK7 | 0.63016786 |
| 78 | MOS | 0.61767380 |
| 79 | MAP3K2 | 0.60865761 |
| 80 | TRIB3 | 0.60629638 |
| 81 | MAP3K6 | 0.58385734 |
| 82 | RIPK1 | 0.58002028 |
| 83 | PAK4 | 0.56941477 |
| 84 | MAP2K6 | 0.55428759 |
| 85 | DAPK2 | 0.54388953 |
| 86 | TTN | 0.52562765 |
| 87 | FYN | 0.51967767 |
| 88 | PDK2 | 0.51357272 |
| 89 | FGFR3 | 0.50896748 |
| 90 | PIK3CG | 0.50592123 |
| 91 | PRKD2 | 0.49950525 |
| 92 | EPHA3 | 0.48831643 |
| 93 | MAP3K12 | 0.47521908 |
| 94 | SGK3 | 0.46810386 |
| 95 | KSR1 | 0.46581445 |
| 96 | MAP3K11 | 0.44272926 |
| 97 | PRKCQ | 0.44262138 |
| 98 | RPS6KA6 | 0.43520083 |
| 99 | MAPKAPK2 | 0.43471130 |
| 100 | CDK6 | 0.42059123 |
| 101 | MAP3K10 | 0.40953351 |
| 102 | SIK2 | 0.40880402 |
| 103 | IGF1R | 0.39679076 |
| 104 | PTK6 | 0.36594247 |
| 105 | RAF1 | 0.35326102 |
| 106 | RPS6KL1 | 0.35255003 |
| 107 | RPS6KC1 | 0.35255003 |
| 108 | MAP2K4 | 0.34379536 |
| 109 | CAMKK1 | 0.34225960 |
| 110 | PKN2 | 0.33978833 |
| 111 | STK24 | 0.32971196 |
| 112 | PDPK1 | 0.32043123 |
| 113 | PDK1 | 0.31828653 |
| 114 | RPS6KA2 | 0.31664682 |
| 115 | MAP3K1 | 0.29985044 |
| 116 | IRAK1 | 0.28753005 |
| 117 | PRKCH | 0.28409187 |
| 118 | MAP3K5 | 0.27603312 |
| 119 | PRKG2 | 0.27017621 |
| 120 | CAMK1D | 0.26526402 |
| 121 | TAOK2 | 0.26379335 |
| 122 | ALK | 0.25746624 |
| 123 | TNK2 | 0.25289408 |
| 124 | SCYL2 | 0.24969164 |
| 125 | FGFR4 | 0.23295969 |
| 126 | MAPK4 | 0.22320736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.04629872 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.59077023 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.88658964 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.71094889 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.67249315 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.67131544 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.61804048 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58769898 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.51359037 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.39255530 |
| 11 | Phagosome_Homo sapiens_hsa04145 | 2.38847113 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.33442911 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.28849922 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23038842 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.22623888 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.16908522 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 2.07464782 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 2.00874430 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.88599249 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82923083 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82471702 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73294741 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63487036 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.62882947 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55762564 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53077484 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52467962 |
| 28 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51440825 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50344324 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49654590 |
| 31 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47341501 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.46065157 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43083268 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.39347226 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31668864 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.31033788 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25540196 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20518697 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17659935 |
| 40 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17377047 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15489954 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14455566 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13682001 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.13501113 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10470443 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.10376255 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08145842 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07215308 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06626964 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.03446598 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97067985 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96245081 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.90578614 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.84862266 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79872355 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74637848 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.73900763 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71030239 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.70721918 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69564093 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69342726 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56518193 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52860247 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52698187 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51366843 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51111769 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50346315 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.49992216 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49443548 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49089201 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.47788624 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47557020 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46679116 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46111712 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45189818 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44938946 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42584023 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42482746 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.41406873 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41102536 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40575290 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39940358 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39643073 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37142156 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36940224 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36863586 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35949446 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35521555 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34821149 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33209100 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31913776 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31361467 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31076741 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31009135 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30152207 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28540507 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28201528 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24761099 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24491638 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24078687 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22026450 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21946053 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18847133 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18442746 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.15896330 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.15580094 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13613440 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13145136 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12185971 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.11893564 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10547735 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.10486869 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09006905 |

